Estimating the Budget Impact of Crizotinib for Alk-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in Argentina
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.433
https://www.valueinhealthjournal.com/article/S1098-3015(14)00484-7/fulltext
Section Title :
Cancer
Section Order :
1477
First Page :
A74
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00484-7&doi=10.1016/j.jval.2014.03.433